List view / Grid view
A total of DKK 8.5 billion will fund the new…
A total of DKK 8.5 billion will fund the new production facility in Odense, Denmark, which is set to facilitate the manufacture of medicines for rare diseases.
Novo Nordisk plans to allocate $6.8 billion towards production to…
Novo Nordisk plans to allocate $6.8 billion towards production to expand its overall US manufacturing capacity.
A major manufacturing facility expansion in Denmark will aim to…
A major manufacturing facility expansion in Denmark will aim to “reduce water consumption with approximately 40 percent and energy consumption with approximately 50 percent compared to similar API processes in other facilities”, according to Novo Nordisk.
Danish pharmaceutical company Novo Nordisk plans to invest € 2.1bn…
Danish pharmaceutical company Novo Nordisk plans to invest € 2.1bn to expand its production facility north of Copenhagen.
